Vanderbilt University / VICC — Nashville, Tennessee

Vanderbilt University / VICC is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt University / VICC has participated in 1 clinical trials.

Therapeutic areas: Esophageal Neoplasms, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer.

Sponsors: Leap Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University / VICC?

Vanderbilt University / VICC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University / VICC conducted?

Vanderbilt University / VICC has 1 clinical trials on record. Their work covers Esophageal Neoplasms, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer.

Is Vanderbilt University / VICC accredited by Crixeo Health?

Vanderbilt University / VICC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University / VICC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.